India's Mid-Market May 2026: Fintech, Synbio, and Deeptech Series A/B Deals
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
Understanding venture capital market dynamics helps founders time their raises and helps investors spot durable themes. Our market analysis covers deal flow, sector concentration, valuation benchmarks, and geographic shifts across the global startup ecosystem.
Browse market analysis articles for data-driven insight into venture capital trends.
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
European tech funding rebounded to €10.5B in May 2026 as mega-rounds powered a market recovery led by defense, deeptech, and sovereign technology.
May 2026 was the second-largest venture month on record — but strip out Anthropic's $50B and the real story is concentration, defense, and the reopening exit window.
D2C food brand Anveshan raised ₹121 crore (~$12.7M) Series B led by Vertex Ventures and IFC in May 2026, roughly doubling its valuation on a rural-sourcing model.
C2i Semiconductors raised a $16.7M Series A extension led by TDK Ventures and Peak XV in May 2026, advancing India's push into semiconductor design.
Corgi Insurance stacked a $160M Series B and a $106M Series B1 within weeks in May 2026, reaching a $2.6B valuation for its AI-native insurance platform.